<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-VXPABOMQ/e00636ff-0569-45fa-b7c8-a7ef38d536f0/PDF"><dcterms:extent>110 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-VXPABOMQ/89695249-90bf-4845-987f-cddf4aec89bc/TEXT"><dcterms:extent>25 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-VXPABOMQ"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2008</dcterms:issued><dc:creator>Hojs, Nina</dc:creator><dc:creator>Hrovat, Eva</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:47</dc:format><dc:format xml:lang="sl">str. 43-49</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:24581081</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-VXPABOMQ</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="sl">ateroskleroza</dc:subject><dc:subject xml:lang="en">Coronary Arteriosclerosis</dc:subject><dc:subject xml:lang="en">Inflammation</dc:subject><dc:subject xml:lang="sl">Koronarna arterioskleroza</dc:subject><dc:subject xml:lang="sl">koronarne arterije</dc:subject><dc:subject xml:lang="en">Neovascularization, Physiologic</dc:subject><dc:subject xml:lang="sl">Neovaskularizacija fiziološka</dc:subject><dc:subject xml:lang="sl">ožilje</dc:subject><dc:subject xml:lang="en">Vasa Vasorum</dc:subject><dc:subject xml:lang="sl">Vaza vazorum</dc:subject><dc:subject xml:lang="sl">vnetja</dc:subject><dc:subject xml:lang="sl">Vnetje</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q28751248" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Vasa vasorum in ateroskleroza koronarnih arterij| Vasa Vasorum and atherosclerosis of coronary arteries|</dc:title><dc:description xml:lang="sl">Vasa vasorum ("vessels of the vessel) are arterioles, capillaries and venules that nourish large arteries and veins. They are derived either from the main blood vessel itself in the case of arteries, and for veins from adjacent arteries as venous vasa vasorum. Atherosclerosis is a systemic dysfunctional endothelial, chronic inflammatory, fibro-proliferative, prothrombotic, angiogenic, multifactorial disease of the arterial intima caused by the retention of modified low-density lipoproteins, along with hemodynamic and redox stress. The first condition for the development of atherosclerosis involves high LDL cholesterol blood levels. The infiltration, retention and modification of excess LDL cholesterol in the arterial intima cause the induction of endothelial cells and consecutive migration of leukocytes into the subendothelial space. Macrophages and lymphocytes inside the arterial intima cause inflammation and tissue damage. A plaque forms, and the thickening of the intima leads to hypoxia and consecutive angiogenesis. Newly formed vasa vasorum destabilize the plaque and cause progression of atherosclerosis. An unstable plaque can rupture and this is strongly associated with vascular occlusion, myocardial ischemia, and infarction. However, vasa vasorum play a positive role when it comes co the regression of atherosclerosis as they may provide a pathway for the removal of incimal fat. Many questions are raised about the best treatment for atherosclerosis.'fbe beneficial effects of statins have already been proven, while other attractivefuture treatments comprise powerful immunosuppressive and antiinflammatory agents, therapeutic angiogenesis and anti-angiogenesis. Finally, vaccination is also an attractive approach to induce protective immunity</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-VXPABOMQ"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-VXPABOMQ" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-VXPABOMQ/e00636ff-0569-45fa-b7c8-a7ef38d536f0/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-VXPABOMQ/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-VXPABOMQ" /></ore:Aggregation></rdf:RDF>